Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition
BI 836880(一种双重血管内皮生长因子和血管生成素 2 抑制剂)单独使用和与程序性细胞死亡蛋白 1 抑制剂联合使用时的药效学和抗肿瘤活性
期刊:Journal of Pharmacology and Experimental Therapeutics
影响因子:3.1
doi:10.1124/jpet.122.001255
Irmgard Hofmann, Anke Baum, Marco H Hofmann, Francesca Trapani, Claudia Reichel-Voda, Diane Ehrensperger, Martin Aichinger, Florian Ebner, Nicole Budano, Norbert Schweifer, Martina Sykora, Erik Depla, Joachim Boucneau, Andreas Gschwind, Norbert Kraut, Frank Hilberg, Klaus-Peter Künkele